In SCLC1, we detected a candidate fusion of the N terminus of the arginyltransferase ATE1 to the pointed (PNT), DNA binding and transactivation domains of ERG, an ETS-family transcription factor subject to frequent GOF fusion events in prostate cancer [18]. Here, ATE1 is linked to prostate carcinoma.